Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christian Götting

Showing results (51-60 of 86) with videos related to

Pageof 9
Sort By:
International Journal of Vascular Medicine|October 24, 2012
Benfotiamine counteracts smoking-induced vascular dysfunction in healthy smokersAlin Stirban, Simona Nandrean, Stanley Kirana, et al.
Diabetes Care|July 17, 2007
Adiponectin decreases postprandially following a heat-processed meal in individuals with type 2 diabetes: an effect prevented by benfotiamine and cooking methodAlin Stirban, Monica Negrean, Bernd Stratmann, et al.
Diabetes Care|December 15, 2012
Acute macrovascular dysfunction in patients with type 2 diabetes induced by ingestion of advanced glycated β-lactoglobulinsAlin Stirban, Paraskevi Kotsi, Knut Franke, et al.
Thrombosis Research|June 9, 2004
Genetic variations in the human TFPI-2 gene and its promoter region by denaturing high performance liquid chromatographySabine Siegling, Elmar Thyzel, Thomas Brinkmann, et al.
Diabetes Care|September 28, 2006
The xylosyltransferase I gene polymorphism c.343G>T (p.A125S) is a risk factor for diabetic nephropathy in type 1 diabetesSylvia Schön, Christian Prante, Claudia Bahr, et al.
Biochemical and Biophysical Research Communications|June 7, 2005
Xylosyltransferase I acceptor properties of fibroblast growth factor and its fragment bFGF (1-24)Joachim Kuhn, Martina Schnölzer, Sylvia Schön, et al.
Clinical Biochemistry|April 12, 2005
Serum xylosyltransferase I activity, the new biochemical fibrosis marker, is not affected by renal insufficiencyManuela Schöttler, Sandra Müller, Sylvia Schön, et al.
American Journal of Hypertension|February 7, 2009
Xylosyltransferase gene variants and their role in essential hypertensionClaudia Pönighaus, Helen J L Speirs, Brian J Morris, et al.
Lipids in Health and Disease|July 28, 2014
ABCC6- a new player in cellular cholesterol and lipoprotein metabolism?Patricia Kuzaj, Joachim Kuhn, Mareike Dabisch-Ruthe, et al.
The Journal of Biological Chemistry|August 6, 2004
Analysis of the DXD motifs in human xylosyltransferase I required for enzyme activityChristian Götting, Sandra Müller, Manuela Schöttler, et al.
Pageof 9

Showing results (51-60 of 86) with videos related to

Sort By:
Pageof 9
International Journal of Vascular Medicine|October 24, 2012
Benfotiamine counteracts smoking-induced vascular dysfunction in healthy smokersAlin Stirban, Simona Nandrean, Stanley Kirana, et al.
Diabetes Care|July 17, 2007
Adiponectin decreases postprandially following a heat-processed meal in individuals with type 2 diabetes: an effect prevented by benfotiamine and cooking methodAlin Stirban, Monica Negrean, Bernd Stratmann, et al.
Diabetes Care|December 15, 2012
Acute macrovascular dysfunction in patients with type 2 diabetes induced by ingestion of advanced glycated β-lactoglobulinsAlin Stirban, Paraskevi Kotsi, Knut Franke, et al.
Thrombosis Research|June 9, 2004
Genetic variations in the human TFPI-2 gene and its promoter region by denaturing high performance liquid chromatographySabine Siegling, Elmar Thyzel, Thomas Brinkmann, et al.
Diabetes Care|September 28, 2006
The xylosyltransferase I gene polymorphism c.343G>T (p.A125S) is a risk factor for diabetic nephropathy in type 1 diabetesSylvia Schön, Christian Prante, Claudia Bahr, et al.
Biochemical and Biophysical Research Communications|June 7, 2005
Xylosyltransferase I acceptor properties of fibroblast growth factor and its fragment bFGF (1-24)Joachim Kuhn, Martina Schnölzer, Sylvia Schön, et al.
Clinical Biochemistry|April 12, 2005
Serum xylosyltransferase I activity, the new biochemical fibrosis marker, is not affected by renal insufficiencyManuela Schöttler, Sandra Müller, Sylvia Schön, et al.
American Journal of Hypertension|February 7, 2009
Xylosyltransferase gene variants and their role in essential hypertensionClaudia Pönighaus, Helen J L Speirs, Brian J Morris, et al.
Lipids in Health and Disease|July 28, 2014
ABCC6- a new player in cellular cholesterol and lipoprotein metabolism?Patricia Kuzaj, Joachim Kuhn, Mareike Dabisch-Ruthe, et al.
The Journal of Biological Chemistry|August 6, 2004
Analysis of the DXD motifs in human xylosyltransferase I required for enzyme activityChristian Götting, Sandra Müller, Manuela Schöttler, et al.
Pageof 9